의약품 포장기계 시장 : 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the pharmaceutical packaging machinery market size was valued at USD 6.62 billion in 2025 and estimated to grow from USD 7.09 billion in 2026 to reach USD 10.02 billion by 2031, at a CAGR of 7.15% during the forecast period (2026-2031).

This report is Segmented by Machinery Type (Primary, Secondary, Labelling and Serialization, and Tertiary), Automation Level (Manual, Semi-Automatic, and Automatic), Packaging Format (Blister, Bottle/Vial, Sachet and Stick Pack, and Cartoning and Case Packing), Application (Solid, Liquid, Semi-Solids, and Parenterals), and Geography. The Market Forecasts are Provided in Terms of Value (USD).

Global Pharmaceutical Packaging Machinery Market Trends and Insights

Stringent Serialization and Track and Trace Regulations

Drug traceability laws require unit-level identifiers and aggregation from blister cavity to pallet, converting packaging machinery into essential compliance infrastructure. The U.S. DSCSA mandated fully interoperable traceability by November 2023, and by late 2024, more than 70% of domestic sites had installed serialization modules; however, case-level aggregation gaps persist. Europe's directive enforces unique identifiers and tamper-evident closures, prompting retrofit cycles across legacy blister and bottle lines. China extended its deadline to 2025 for import drugs, spurring contract manufacturers that serve Western markets to fast-track equipment purchases. Supplier software now ships with region-specific compliance templates; however, this localization increases the total cost of ownership and validation timelines in the pharmaceutical packaging machinery market. ISO 15378 has become a de facto tender prerequisite, narrowing vendor pools to firms that can align equipment files with Good Manufacturing Practice records.

Rapid Growth of Biologics and Injectable Drugs

Eight of the top 10 therapies sold in 2024 were biologics packaged in vials, syringes, or autoinjectors that require ISO Class 5 environments and precise glass handling. The FDA issued 47 warning letters in 2024 for particulate contamination, reinforcing the zero-defect mandate and driving the installation of automated visual inspection cameras. Small batch sizes of gene and cell therapies make high-speed legacy fillers uneconomic, so modular machines capable of 30-minute format changes are preferred. The European Medicines Agency cleared 92 biologics in 2024, each requiring dedicated packaging validation runs that many firms outsource to flexible contract development and manufacturing partners. Suppliers respond with servo-driven dosing pumps and single-use flow paths that maintain sterility and shorten cleaning cycles.

High Capital Expenditure for Advanced Machinery

Aseptic lines incorporating isolators, serialization modules, and in-line particle inspection can top USD 8 million, locking many generic manufacturers into aging assets. Forty percent of plants in emerging regions operate equipment that is more than 15 years old, compared with 12% in North America, widening a compliance gap that hinders export approvals. Leasing models have emerged, yet data-sharing clauses raise concerns about intellectual property. Public lenders, such as the European Investment Bank, offered EUR 500 million (USD 565 million) in loans in 2024 to support Eastern European upgrades, signaling that external financing is essential where private credit costs remain elevated.

Other drivers and restraints analyzed in the detailed report include:

1. Increasing Demand for Automation and Industry 4.0 Integration
2. Rise of Personalized Small-Batch Manufacturing Workflows
3. Stringent Validation and Compliance Complexity

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Primary equipment accounted for 54.18% of the pharmaceutical packaging machinery market in 2025, underscoring its mission-critical role in ensuring container integrity and sterility. However, secondary lines will expand at a faster rate of 8.05% CAGR because case- and pallet-level aggregation has become mandatory for global shipments. The pharmaceutical packaging machinery market size for secondary equipment is forecast to reach USD 3.44 billion by 2031, driven by retrofits that incorporate vision-inspection cameras and two-dimensional code printers. Antares Vision logged a 22% order spike for serialization modules in the Asia-Pacific region, revealing how export-oriented generic manufacturers prioritize downstream upgrades over full-line replacements.

Labeling and serialization machines form the fastest-moving niche, aided by the pharmaceutical packaging machinery market share gains of high-speed inkjet and laser coders operating at more than 400 packs per minute. Blister platforms are experiencing renewed investment as companies shift from bottles to unit-dose packs to enhance adherence, while cartoners are moving up the value chain by integrating variable data printing and tamper-evident sealing. Uhlmann's 2024 modular cartoner allows for seamless switching between tuck-end and glue-seal formats without the need for tools, aligning with the high SKU proliferation of specialty drugs.

Automatic systems accounted for 64.12% of installations in 2025, reflecting wage inflation and the precision needed for zero-defect packaging. The pharmaceutical packaging machinery market growth for automatic equipment is driven by collaborative robots that enable rapid changeovers without interrupting production lines. In India and China, manufacturing wages increased by 8% annually from 2019 to 2024, narrowing the labor arbitrage that once justified manual operations.

Semi-automatic machines still appeal to clinical-trial sites and emerging-market factories where product diversity outweighs throughput. Romaco reports that 35% of its emerging-market sales are semi-automatic units, serving as stepping-stones toward full automation. Marchesini's collaborative cartoning cells, deployed in 2024, slash changeover times from 45 to 12 minutes, demonstrating how hybrid human-robot cells bridge capability gaps until skilled mechatronics labor pools mature.

Complete Report Scope:

• By Machinery Type
  • Primary Packaging Equipment
  • Secondary Packaging Equipment
  • Labelling and Serialization Equipment
  • Tertiary Packaging Equipment
• By Automation Level
  • Manual
  • Semi-Automatic
  • Automatic
• By Packaging Format
  • Blister Packaging
  • Bottle/Vial Packaging
  • Sachet and Stick Pack
  • Cartoning and Case Packing
• By Application
  • Solids (Tablets/Capsules)
  • Liquids
  • Semi-Solids
  • Parenterals (Injectables)
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Chile
    • Rest of South America
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia and New Zealand
    • Rest of Asia-Pacific
  • Middle East and Africa
    • Middle East
      • United Arab Emirates
      • Saudi Arabia
      • Turkey
      • Rest of Middle East
    • Africa
      • South Africa
      • Kenya
      • Nigeria
      • Rest of Africa

Geography Analysis

North America represents the largest regional base, accounting for 39.10% of 2025 revenue, thanks to DSCSA enforcement, reshoring incentives, and tax credits that subsidize capital outlays for sterile-fill projects in states such as North Carolina and Massachusetts. Investments in digital twins and energy monitoring aim to reduce commissioning time and operating expenses. Contract manufacturers in the United States are increasingly requiring turnkey solutions with validation documentation pre-aligned to FDA electronic record standards, thereby shortening the time to market.

The Asia-Pacific region exhibits the fastest trajectory, forecast at a 9.30% CAGR, driven by Indian and Chinese factories that seek to meet export specifications for the United States and the European Union. India shipped USD 27.9 billion in finished drugs in fiscal 2024, and this export dependency motivates firms to install European-grade serialization and vision systems. Chinese authorities have extended the serialization compliance deadline for imports to 2025, creating a short-term equipment procurement boom among export-oriented contract manufacturers.

Europe maintains a steady demand tied to replacement cycles rather than plant expansions. Manufacturers retrofit bottle, blister, and vial lines with aggregation cameras to comply with the EU directive's full enforcement, which is expected to be reached in 2024, while energy-efficiency upgrades mitigate regionally high electricity costs. Germany, Italy, and Switzerland remain global engineering hubs, home to Syntegon, IMA, and Marchesini, which creates a dense service network that multinational drugmakers favor when sourcing equipment partners.

South America and the Middle East, and Africa contribute smaller shares but offer targeted opportunities tied to domestic production policies. Brazil and Argentina introduced serialization regulations modeled after the DSCSA, stimulating the purchase of inkjet coders and case aggregators. Gulf Cooperation Council states are promoting local vaccine fill-finish plants under economic diversification frameworks, and suppliers who bundle training and validation support gain an early-mover advantage in these nascent markets.

1. Syntegon Technology GmbH
2. IMA S.p.A.
3. Marchesini Group S.p.A.
4. Uhlmann Group
5. Romaco Holding GmbH
6. Optima Packaging Group GmbH
7. MULTIVAC Group
8. Korber AG (Medipak Systems)
9. Antares Vision Group S.p.A.
10. Coesia S.p.A.
11. Bausch + Strobel Maschinenfabrik Ilshofen GmbH + Co. KG
12. ACG Packaging Private Limited
13. Ishida Co. Ltd.
14. PAC Machinery Group Inc.
15. Accutek Packaging Equipment Companies Inc.
16. Vanguard Pharmaceutical Machinery Inc.
17. MG2 s.r.l.
18. Becton Dickinson and Company
19. SSI SCHAFER Group
20. Herma GmbH
21. Videojet Technologies Inc.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET LANDSCAPE

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Stringent Serialization and Track and Trace Regulations
  • 4.2.2 Rapid Growth of Biologics and Injectable Drugs
  • 4.2.3 Increasing Demand for Automation and Industry 4.0 Integration
  • 4.2.4 Rise of Personalized Small-Batch Manufacturing Workflows
  • 4.2.5 Reshoring and Nearshoring of Pharma Supply Chains in Response to Geopolitical Strains
  • 4.2.6 Energy-Efficient Machinery Becoming a Procurement Criterion Amid ESG Targets
• 4.3 Market Restraints
  • 4.3.1 High Capital Expenditure for Advanced Machinery
  • 4.3.2 Stringent Validation and Compliance Complexity
  • 4.3.3 Semiconductor and Servo Drive Shortages Disrupting Equipment Lead Times
  • 4.3.4 Limited Availability of Skilled Mechatronics Talent for Line Integration
• 4.4 Industry Value Chain Analysis
• 4.5 Impact of Macroeconomic Factors on the Market
• 4.6 Regulatory Landscape
• 4.7 Technological Outlook
• 4.8 Porter's Five Forces Analysis
  • 4.8.1 Threat of New Entrants
  • 4.8.2 Bargaining Power of Buyers
  • 4.8.3 Bargaining Power of Suppliers
  • 4.8.4 Threat of Substitute Products
  • 4.8.5 Intensity of Competitive Rivalry

5 MARKET SIZE AND GROWTH FORECASTS (VALUE)

• 5.1 By Machinery Type
  • 5.1.1 Primary Packaging Equipment
  • 5.1.2 Secondary Packaging Equipment
  • 5.1.3 Labelling and Serialization Equipment
  • 5.1.4 Tertiary Packaging Equipment
• 5.2 By Automation Level
  • 5.2.1 Manual
  • 5.2.2 Semi-Automatic
  • 5.2.3 Automatic
• 5.3 By Packaging Format
  • 5.3.1 Blister Packaging
  • 5.3.2 Bottle/Vial Packaging
  • 5.3.3 Sachet and Stick Pack
  • 5.3.4 Cartoning and Case Packing
• 5.4 By Application
  • 5.4.1 Solids (Tablets/Capsules)
  • 5.4.2 Liquids
  • 5.4.3 Semi-Solids
  • 5.4.4 Parenterals (Injectables)
• 5.5 By Geography
  • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
  • 5.5.2 South America
    • 5.5.2.1 Brazil
    • 5.5.2.2 Argentina
    • 5.5.2.3 Chile
    • 5.5.2.4 Rest of South America
  • 5.5.3 Europe
    • 5.5.3.1 United Kingdom
    • 5.5.3.2 Germany
    • 5.5.3.3 France
    • 5.5.3.4 Italy
    • 5.5.3.5 Spain
    • 5.5.3.6 Rest of Europe
  • 5.5.4 Asia-Pacific
    • 5.5.4.1 China
    • 5.5.4.2 Japan
    • 5.5.4.3 India
    • 5.5.4.4 South Korea
    • 5.5.4.5 Australia and New Zealand
    • 5.5.4.6 Rest of Asia-Pacific
  • 5.5.5 Middle East and Africa
    • 5.5.5.1 Middle East
      • 5.5.5.1.1 United Arab Emirates
      • 5.5.5.1.2 Saudi Arabia
      • 5.5.5.1.3 Turkey
      • 5.5.5.1.4 Rest of Middle East
    • 5.5.5.2 Africa
      • 5.5.5.2.1 South Africa
      • 5.5.5.2.2 Kenya
      • 5.5.5.2.3 Nigeria
      • 5.5.5.2.4 Rest of Africa

6 COMPETITIVE LANDSCAPE

• 6.1 Market Concentration
• 6.2 Strategic Moves
• 6.3 Market Share Analysis
• 6.4 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products and Services, and Recent Developments)
  • 6.4.1 Syntegon Technology GmbH
  • 6.4.2 IMA S.p.A.
  • 6.4.3 Marchesini Group S.p.A.
  • 6.4.4 Uhlmann Group
  • 6.4.5 Romaco Holding GmbH
  • 6.4.6 Optima Packaging Group GmbH
  • 6.4.7 MULTIVAC Group
  • 6.4.8 Korber AG (Medipak Systems)
  • 6.4.9 Antares Vision Group S.p.A.
  • 6.4.10 Coesia S.p.A.
  • 6.4.11 Bausch + Strobel Maschinenfabrik Ilshofen GmbH + Co. KG
  • 6.4.12 ACG Packaging Private Limited
  • 6.4.13 Ishida Co. Ltd.
  • 6.4.14 PAC Machinery Group Inc.
  • 6.4.15 Accutek Packaging Equipment Companies Inc.
  • 6.4.16 Vanguard Pharmaceutical Machinery Inc.
  • 6.4.17 MG2 s.r.l.
  • 6.4.18 Becton Dickinson and Company
  • 6.4.19 SSI SCHAFER Group
  • 6.4.20 Herma GmbH
  • 6.4.21 Videojet Technologies Inc.

7 MARKET OPPORTUNITIES AND FUTURE OUTLOOK

• 7.1 White-Space and Unmet-Need Assessment